C140H130BBr3Cl6F10N23O9+ — CID 159629302
1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;bis(6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-yl-2-(2-pyridin-2-ylethyl)quinazoline);[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-ylquinazolin-2-yl]methanamine;1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-hydroxypyridin-1-ium;prop-2-enoyl chloride;tribromoborane (PubChem CID 159629302) has the molecular formula C140H130BBr3Cl6F10N23O9+ and a molecular weight of 2931.95 g/mol. Its IUPAC name is 1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;bis(6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-yl-2-(2-pyridin-2-ylethyl)quinazoline);[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-ylquinazolin-2-yl]methanamine;1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-hydroxypyridin-1-ium;prop-2-enoyl chloride;tribromoborane.
| Compound Name | 1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;bis(6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-yl-2-(2-pyridin-2-ylethyl)quinazoline);[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-ylquinazolin-2-yl]methanamine;1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-hydroxypyridin-1-ium;prop-2-enoyl chloride;tribromoborane |
|---|---|
| PubChem CID | 159629302 |
| Molecular Formula | C140H130BBr3Cl6F10N23O9+ |
| Molecular Weight | 2931.95 g/mol |
| Exact Mass | 2924.60 |
| IUPAC Name | 1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;bis(6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-yl-2-(2-pyridin-2-ylethyl)quinazoline);[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-4-piperidin-1-ylquinazolin-2-yl]methanamine;1-[4-[6-chloro-8-fluoro-7-(2-fluoro-6-methoxyphenyl)-2-(2-pyridin-2-ylethyl)quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-hydroxypyridin-1-ium;prop-2-enoyl chloride;tribromoborane |
| SMILES | BrB(Br)Br.C=CC(=O)Cl.C=CC(=O)N1CCN(c2nc(CCc3ccccn3)nc3c(F)c(-c4c(F)cccc4OC)c(Cl)cc23)CC1.C=CC(=O)N1CCN(c2nc(CCc3ccccn3)nc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1.COc1cccc(F)c1-c1c(Cl)cc2c(N3CCCCC3)nc(CCc3ccccn3)nc2c1F.COc1cccc(F)c1-c1c(Cl)cc2c(N3CCCCC3)nc(CCc3ccccn3)nc2c1F.COc1cccc(F)c1-c1c(Cl)cc2c(N3CCCCC3)nc(CN)nc2c1F.O[n+]1ccccc1 |
| InChI | InChI=1S/C29H26ClF2N5O2.C28H24ClF2N5O2.2C27H25ClF2N4O.C21H21ClF2N4O.C5H6NO.C3H3ClO.BBr3/c1-3-24(38)36-13-15-37(16-14-36)29-19-17-20(30)25(26-21(31)8-6-9-22(26)39-2)27(32)28(19)34-23(35-29)11-10-18-7-4-5-12-33-18;1-2-23(38)35-12-14-36(15-13-35)28-18-16-19(29)24(25-20(30)7-5-8-21(25)37)26(31)27(18)33-22(34-28)10-9-17-6-3-4-11-32-17;2*1-35-21-10-7-9-20(29)24(21)23-19(28)16-18-26(25(23)30)32-22(12-11-17-8-3-4-13-31-17)33-27(18)34-14-5-2-6-15-34;1-29-15-7-5-6-14(23)18(15)17-13(22)10-12-20(19(17)24)26-16(11-25)27-21(12)28-8-3-2-4-9-28;7-6-4-2-1-3-5-6;1-2-3(4)5;2-1(3)4/h3-9,12,17H,1,10-11,13-16H2,2H3;2-8,11,16,37H,1,9-10,12-15H2;2*3-4,7-10,13,16H,2,5-6,11-12,14-15H2,1H3;5-7,10H,2-4,8-9,11,25H2,1H3;1-5,7H;2H,1H2;/q;;;;;+1;; |
| InChIKey | FGYUHANVDPJWRL-UHFFFAOYSA-N |
| XLogP | 31.01 |
| TPSA | 361.63 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 192 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2931.95 |
| LogP ≤ 5 | 31.01 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 29 |
| Structural Alerts | {'alert_name': 'acid_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'N-hydroxyl_pyridine', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|